Can Rabies Vaccines be given with or after COVID-19 Vaccines and Vice Versa?

  • Omesh Kumar Bharti State Epidemiologist from Shimla, Himachal Pradesh, India.
  • Jugal Kishore Director Professor & Head Department of Community Medicine, VMMC & SJH, New Delhi.
Keywords: Rabies Vaccines, COVID-19 Vaccines


Rabies is a dreaded disease and kills about 59,0001 persons every year. The ongoing COVID-19 pandemic has also killed about 3.9 million2 people since it started last year in 2020. The recent fast track development of vaccines against COVID-19 has emerged as a hope to contain the pandemic. Questions are being asked about whether one can take rabies vaccine with or after COVID-19 vaccination and vice versa. Rabies is caused by a single-stranded RNA virus belonging to Lyssavirus genus of the family Rhabdoviridae. These viruses are enveloped and have a single-stranded RNA genome with negative-sense and cause neurological symptoms and encephalitis. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense, single-stranded RNA virus that causes the potentially lethal COVID-19 respiratory tract infection. This new SARS-CoV-2 virus belongs to the genus Betacoronavirus, which also includes Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The doctors fear any adverse cross-reaction between the two vaccines because both rabies and COVID-19 viruses are RNA viruses.


Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin FX, Metlin A, Miranda ME, Muller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Vigilato MA, Zinsstag J, Dushoff J; Global Alliance for Rabies Control Partners for Rabies Prevention. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709. [PubMed] [Google Scholar]

Worldometer [Internet]. Available from:

Bharti OK, Thakur B, Rao R. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by “pooling strategy”. Vaccine. 2019;37(Suppl 1): A128-A131. [PubMed] [Google Scholar]

Poddar S, Mukherjee D, Roy R. Anti rabies vaccination in presence of COVID-19 affected patient accidentally associated with HIV infection. APCRI J. 2021;22(2):71-4.

Kato H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, Posadas-Herrera G, Horiya M, Satoh M, Yoshikawa T, Yamada S, Harada S, Fujii H, Shibamura M, Inagaki T, Morimoto K, Saijo M, Lim CK. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. PLoS One. 2019 Oct 7;14(10):e0223684. [PubMed] [Google Scholar]

Kurup D, Wirblich C, Ramage H, Schnell MJ. Rabies virusbased COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2. NPJ Vaccines. 2020;5:98. [PubMed] [Google Scholar]

Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol. 2011 Oct;85(20):10605-16. [PubMed] [Google Scholar]